![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir:
Drug Interactions with Antiretroviral Agents
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
Washington D.C., May 26-28, 2015
Rajeev Menon Ph.D.
AbbVie Inc.
![Pharm1.gif](../images/060115/060115-6/Pharm1.gif)
![Pharm2.gif](../images/060115/060115-6/Pharm2.gif)
![Pharm3.gif](../images/060115/060115-6/Pharm3.gif)
![Pharm4.gif](../images/060115/060115-6/Pharm4.gif)
![Pharm5.gif](../images/060115/060115-6/Pharm5.gif)
![Pharm6.gif](../images/060115/060115-6/Pharm6.gif)
![Pharm7.gif](../images/060115/060115-6/Pharm7.gif)
![Pharm8.gif](../images/060115/060115-6/Pharm8.gif)
![Pharm9.gif](../images/060115/060115-6/Pharm9.gif)
![Pharm10.gif](../images/060115/060115-6/Pharm10.gif)
![Pharm11.gif](../images/060115/060115-6/Pharm11.gif)
![Pharm12.gif](../images/060115/060115-6/Pharm12.gif)
![Pharm13.gif](../images/060115/060115-6/Pharm13.gif)
![Pharm14.gif](../images/060115/060115-6/Pharm14.gif)
![Pharm15.gif](../images/060115/060115-6/Pharm15.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|